0001104659-22-077707.txt : 20220706
0001104659-22-077707.hdr.sgml : 20220706
20220706161817
ACCESSION NUMBER: 0001104659-22-077707
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dowden Nathan J
CENTRAL INDEX KEY: 0001873392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40969
FILM NUMBER: 221068931
MAIL ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entrada Therapeutics, Inc.
CENTRAL INDEX KEY: 0001689375
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813983399
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-305-1825
MAIL ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: CycloPorters, Inc.
DATE OF NAME CHANGE: 20161104
4
1
tm2220515-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-07-01
0
0001689375
Entrada Therapeutics, Inc.
TRDA
0001873392
Dowden Nathan J
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET
BOSTON
MA
02210
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
12.00
2022-07-01
4
A
0
33788
0
A
2032-07-01
Common stock
33788
33788
D
25% of the option shares shall vest and become exercisable on July 1, 2023, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, such that the option shares will be fully vested on July 1, 2026.
/s/ Jared Cohen, as Attorney-in-Fact
2022-07-06